Stacy Ku
Stock Analyst at TD Cowen
(4.39)
# 1,216
Out of 4,504 analysts
144
Total ratings
56%
Success rate
12.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stacy Ku
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AUPH Aurinia Pharmaceuticals | Maintained: Buy | $17 | $15.78 | +7.73% | 14 | Jul 6, 2026 | |
| TNXP Tonix Pharmaceuticals Holding | Maintained: Buy | $22 | $12.53 | +75.58% | 3 | Jun 29, 2026 | |
| AVTX Avalo Therapeutics | Maintained: Buy | n/a | $19.21 | - | 4 | Jun 11, 2026 | |
| SLGL Sol-Gel Technologies | Initiated Coverage: Buy | n/a | $73.95 | - | 1 | May 29, 2026 | |
| TARA Protara Therapeutics | Rated: Buy | n/a | $4.32 | - | 14 | May 20, 2026 | |
| VRCA Verrica Pharmaceuticals | Maintained: Buy | $20 | $6.26 | +219.49% | 14 | May 12, 2026 | |
| LENZ LENZ Therapeutics | Maintained: Buy | $60 | $5.59 | +973.35% | 17 | May 11, 2026 | |
| BCRX BioCryst Pharmaceuticals | Maintained: Buy | $30 | $10.45 | +187.08% | 16 | May 6, 2026 | |
| SUPN Supernus Pharmaceuticals | Maintained: Buy | $65 | $48.46 | +34.13% | 20 | May 5, 2026 | |
| LON: 0NZT UCB SA | Maintained: Buy | €310.00 → €305.00 | $250.17 | +21.92% | 23 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 → $8 | $2.45 | +226.53% | 2 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $165 → $175 | $135.91 | +28.76% | 6 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2 | $0.6376 | +213.68% | 8 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $7.67 | - | 1 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $20.36 | n/a | 1 | Feb 26, 2025 |
Aurinia Pharmaceuticals
Jul 6, 2026
Maintained: Buy
Price Target: $17
Current: $15.78
Upside: +7.73%
Tonix Pharmaceuticals Holding
Jun 29, 2026
Maintained: Buy
Price Target: $22
Current: $12.53
Upside: +75.58%
Avalo Therapeutics
Jun 11, 2026
Maintained: Buy
Price Target: n/a
Current: $19.21
Upside: -
Sol-Gel Technologies
May 29, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $73.95
Upside: -
Protara Therapeutics
May 20, 2026
Rated: Buy
Price Target: n/a
Current: $4.32
Upside: -
Verrica Pharmaceuticals
May 12, 2026
Maintained: Buy
Price Target: $20
Current: $6.26
Upside: +219.49%
LENZ Therapeutics
May 11, 2026
Maintained: Buy
Price Target: $60
Current: $5.59
Upside: +973.35%
BioCryst Pharmaceuticals
May 6, 2026
Maintained: Buy
Price Target: $30
Current: $10.45
Upside: +187.08%
Supernus Pharmaceuticals
May 5, 2026
Maintained: Buy
Price Target: $65
Current: $48.46
Upside: +34.13%
UCB SA
May 4, 2026
Maintained: Buy
Price Target: €310.00 → €305.00
Current: $250.17
Upside: +21.92%
Apr 23, 2026
Rated: Buy
Price Target: $12 → $8
Current: $2.45
Upside: +226.53%
Mar 13, 2026
Maintained: Buy
Price Target: $165 → $175
Current: $135.91
Upside: +28.76%
Nov 7, 2025
Maintained: Buy
Price Target: $2
Current: $0.6376
Upside: +213.68%
Oct 30, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $7.67
Upside: -
Feb 26, 2025
Maintained: Buy
Price Target: n/a
Current: $20.36
Upside: n/a